| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |